Long-term use of pegfilgrastim in children with severe congenital neutropenia: clinical and pharmacokinetic data.
Unit of Hematology, Istituto Giannina Gaslini, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Genoa, Italy.
Francesca
0000-0002-7096-4580
F
Fioredda
Unit of Hematology, Istituto Giannina Gaslini, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Genoa, Italy.
Tiziana
T
Lanza
Unit of Hematology, Istituto Giannina Gaslini, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Genoa, Italy.
Federica
F
Gallicola
Unit of Hematology, Istituto Giannina Gaslini, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Genoa, Italy.
Francesca
F
Riccardi
Unit of Hematology, Istituto Giannina Gaslini, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Genoa, Italy.
Marina
M
Lanciotti
Unit of Paediatric Oncology and Haematology, Santa Maria della Misericordia Hospital, Perugia, Italy; and.
Elena
E
Mastrodicasa
Unit of Hematology, Istituto Giannina Gaslini, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Genoa, Italy.
Sara
S
Signa
Biostatistic and Epidemiology Unit, Istituto Giannina Gaslini, IRCCS, Genoa, Italy.
Sabrina
S
Zanardi
Unit of Hematology, Istituto Giannina Gaslini, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Genoa, Italy.
Michaela
M
Calvillo
Unit of Hematology, Istituto Giannina Gaslini, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Genoa, Italy.
Carlo
C
Dufour
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D000080984:Congenital Bone Marrow Failure Syndromes; D005260:Female; D000069585:Filgrastim / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D016179:Granulocyte Colony-Stimulating Factor / Q000008:administration & dosage / Q000493:pharmacokinetics; D006801:Humans; D008297:Male; D009503:Neutropenia / Q000151:congenital* / Q000188:drug therapy / Q000378:metabolism; D011092:Polyethylene Glycols / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome
D016179:Granulocyte Colony-Stimulating Factor; C455861:pegfilgrastim; D011092:Polyethylene Glycols; D000069585:Filgrastim